In line with previous reports [42,43,44,45,46], we confirmed that both BMPs inhibited the growth of the MM cell lines L363 and LME-1, and reduced the viability of primary malignant plasma cells from three MM-derived BM samples (Figure 5A,B). Here, CLN5 is linked to Miyoshi myopathy.